-
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Consensus Rating of "Buy" by Analysts
Source: Buzz FX / 01 Jan 2025 04:41:14 America/New_York
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat January 1, 2025 Share Link copied to clipboard. Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX - Get Free Report ) has received a c
Read more...